Fantastic.
Avexa Reports Superior Results in ATC Phase IIb Clinical Trial Update.
48 week data shows 90% of treated patients achieve undetectable viral loads
Key Highlights from the 48 week data.
• Increase in the percentage of patients with viral loads below detectable at week 48 compared to week
24
- Forums
- ASX - By Stock
- AVX
- superior results than 24 wk data this is huge
superior results than 24 wk data this is huge
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online